HopeStage
Back to all studies
CompletedNCT07047820

A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy

Observational studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
WoonsocketSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 30, 2025
Recruitment status
Completed
Enrollment listed in the registry
305
Sponsor
Biogen
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07047820
Official title
Show the full official title

Prospective, Observational Survey Study Assessing Effectiveness of Zuranolone in Improving PPD Symptoms in the Real-world Setting

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Woonsocket

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Biogen.

Did this study involve medication?

Yes. The study involved medication, including Zuranolone.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies